Rekrutierende Studie = ; Fortlaufende Studie = ; Abgeschlossene Studie = ; Förderung durch ein IRDiRC-Mitglied = ; ERN-Mitglied =

Nationale klinische Studie(n)

ITALIEN

LAZIO
ROMA

Phase II Open-label Global Study to Evaluate the Effect of Dabrafenib in Combination With Trametinib in Children and Adolescent Patients With BRAF V600 Mutation Positive Low Grade Glioma (LGG) or Relapsed or Refractory High Grade Glioma (HGG) - IT

IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO

U.O. di Oncoematologia

Mehr Details

NIEDERLANDE

Noord-Holland
AMSTERDAM

The Drug Rediscovery Protocol (DRUP trial): A Dutch National Study on behalf of the Center for Personalized Cancer Treatment (CPCT) to Facilitate Patient Access to Commercially Available, Targeted Anti-cancer Drugs to determine the Potential Efficacy in Treatment of Advanced Cancers with a Known Molecular Profile (Phase II)

Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis

Afdeling Maag-Darm-Leveroncologie

Mehr Details

BELGIEN

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

STEP: Sorafenib Long Term Extension Program - BE

Cliniques universitaires Saint-Luc - UCLouvain

Pneumologie_Oncologie thoracique

Mehr Details

ITALIEN

LAZIO
ROMA

An Open-Label, Single-Arm, Phase 1/2 Study Evaluating the Safety and Efficacy of Ponatinib for the Treatment of Recurrent or Refractory Leukemias or Solid Tumors in Pediatric Participants - IT

IRCCS Ospedale Pediatrico Bambino Gesù - SEDE GIANICOLO

U.O. di Oncoematologia

Mehr Details